Its exact mechanism of action on NLRP3 is unknown; however, its ability to effectively block NLRP3 activation and reduce the synthesis of the pro-inflammatory factor IL-1β has allowed its use for painful strokes and makes it a promising treatment option for stroke [81]. The gene discussed is IL1B; the disease is stroke disorder.